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Abstract: Recovery from injuries to the central nervous system, including
spinal cord injury, is constrained in part by the intrinsically low ability of many
CNS neurons to mount an effective regenerative growth response. To improve
outcomes, it is essential to understand and ultimately reverse these neuronintrinsic constraints. Genetic manipulation of key transcription factors (TFs),
which act to orchestrate production of multiple regeneration-associated
genes, has emerged as a promising strategy. It is likely that no single TF will
be sufficient to fully restore neuron-intrinsic growth potential, and that
multiple, functionally interacting factors will be needed. An extensive
literature, mostly from non-neural cell types, has identified potential
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mechanisms by which TFs can functionally synergize. Here we examine four
potential mechanisms of TF/TF interaction; physical interaction,
transcriptional cross-regulation, signaling-based cross regulation, and cooccupancy of regulatory DNA. For each mechanism, we consider how existing
knowledge can be used to guide the discovery and effective use of TF
combinations in the context of regenerative neuroscience. This mechanistic
insight into TF interactions is needed to accelerate the design of effective TFbased interventions to relieve neuron-intrinsic constraints to regeneration and
to foster recovery from CNS injury.
Keywords: Transcription factor, Axon regeneration, Co-occupancy,
Combination, Network, Spinal cord injury

1. Introduction
Coaxing robust, long distance regeneration from injured neurons
remains a major unmet challenge in the treatment of spinal cord
injury. Although extrinsic barriers to axon regeneration contribute,
cell-intrinsic mechanisms within injured CNS neurons also limit axon
growth.10 and 17 Axon extension requires a profound change in cellular
state within injured neurons. Prior to axotomy, neurons are tasked
with maintaining intracellular communication and structural
homeostasis in far-flung processes; after axotomy, regeneration
demands the production, transport, and regulated assembly of
enormous amounts of cytoskeletal and membranous material. The
sheer number of genes that must be up- or down-regulated to
reinitiate axon extension presents a major challenge to targeting the
neuron-intrinsic growth state.10,47 One possible solution is that
underlying transcription factors (TFs) might be manipulated in injured
neurons, perhaps acting as simple levers to alter the expression of
large numbers of downstream regeneration-associated genes (RAGs).
A growing number of TFs have been functionally linked to axon growth
in a variety of cell types (Table 1). Indeed, manipulation of TFs
including KLFs, SOX11, and STAT3 has enhanced regenerative axon
growth after spinal injury.11,37,85 On the other hand, the number and
regenerative speed of treated axons likely remains well below the
threshold for functional recovery.
Table 1. Summary of regeneration associated TFs (RAG TFs) shown to
regulate axon growth in vivo.
Regeneration
associated TFs
ATF3

Model of regeneration
Sciatic nerve crush

References
Seijjfers et al67
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Regeneration
associated TFs
cJUN

Model of regeneration

References

Facical nerve transection

Raivich et al.65

Sciatic nerve crush

Saijilafu et al.66

CREB

Conditioning lesion

Gao et al.27

KLF7

Pyramidotomy and cervical Blackmore et al.11
SCI

HIF1alpha

Sciatic nerve crush

Cho et al.16

MYC

Optic nerve injury

Belin et al.6

MASH1

Thoracic SCI

Williams et al.87

p53

Facial nerve axotomy

Tedeschi et al.78

SMAD1

Thoracic SCI

Parikh et al.62

SOX11

Saphenous nerve crush

Jankowski et al.35

Pyramidotomy and cervical Wang et al.85
SCI
KLF4

Optic nerve injury

Moore et al.56

STAT3

Saphenous nerve crush

Bareyre et al.5

Dorsal column transectionDRGs
Unilateral pyramidotomy

Lang et al.,201342

Optic nerve injury

Smith et al., Luo et al.49,69

One explanation for this limited response may be that no single
TF is sufficient to drive a full regenerative program. Instead, groups of
functionally interacting factors are likely needed, similar to the
situation in induced pluripotency.74 Indeed, recent work in the optic
system makes it plain that combinatorial gene manipulations are most
effective in producing axon regeneration.6,49,73 Although plausible in
principle, this combinatorial perspective brings with it the challenge of
identifying optimal sets of TFs.77,79 With well over one thousand TFs in
the genome and at least a dozen already linked to regenerative axon
growth in vivo ( Table 1), the number of possible combinations is
daunting.
Here we argue that optimal selection of pro-regenerative TF
combinations requires careful consideration of the underlying
mechanisms of interaction. Fundamentally, the specifics of the various
molecular interactions between TFs have profound implications for the
discovery and eventual use of TF combinations to improve
regenerative axon growth. To illustrate this, we briefly consider four
general mechanisms by which TFs can functionally interact. For the
sake of clarity, we frame the discussion around two-way interactions
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between factors, with the understanding that this basic framework
must eventually be scaled to accommodate multi-factor networks. For
each mechanism we 1) examine instances in which the mechanism has
been demonstrated in TFs linked to axon growth 2) examine how the
mechanism informs improved discovery of TF/TF interactions and 3)
consider the implications of the mechanism for optimal comanipulations. This consideration of the details of TF/TF interactions is
critical to accelerate the discovery of optimal TF mixtures and improve
the efficacy of combinatorial manipulations.

2. Physical interaction
TFs can directly bind to one another and reciprocally influence
activity (Fig. 1). Indeed, some families of TFs, notably bZIP, bHLH,
and STATs, are obligate dimers; the ability to bind DNA is conferred by
the presence of two subunits [reviewed in2]. Obligate dimers form both
homo- and heterodimers, commonly with related family members.
Importantly, transcriptional activity can be increased or suppressed
depending on the specific partnerships formed, creating a system for
graded control of transcription. A highly relevant example involves the
bZIP AP1 factors, JUN and ATF3. Previous work indicates that JUN
homodimers drive moderate activation of target genes and JUN-ATF3
heterodimers drive strong activation, whereas ATF3 homodimers can
act to repress transcription.4 JUN and ATF3 have been individually
linked to axon regeneration,65,67 and single overexpression of each has
been attempted to enhance regenerative outcomes. Intriguingly, it
was recently shown that forced co-expression of both factors is more
effective in promoting axon growth in sensory neurons than either
alone.13 These data raise the possibility that the synergistic effects of
co-expressed JUN and ATF3 in sensory axon growth might be
explained by direct binding, although this possibility has yet to be
directly tested.
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Fig. 1. Transcription factors functionally interact through distinct mechanisms. The
left-hand column illustrates four potential mechanisms of TF/TF interaction. The
middle column lists experimental techniques and bioinformatics resources that can be
used to identify each mechanism. The right-hand column lists the implications of each
mechanism for optimizing the use of multiple TFs for maximal effect.

In addition to obligate dimers, physical interaction between TFs
is also common across TF classes, and between TFs that normally
function as individual subunits (e.g. zinc finger TFs). In one highly
relevant example from optic nerve regeneration, KLF4, which acts to
inhibit axon growth in this system, physically associates with and
inhibits pro-regenerative STAT3 (Qin et al.). In addition, a wide range
of physical interactions between RAG TFs, shown mostly in non-neural
cell types, are summarized in Fig. 2 (references provided as hyperlinks
in Supplementary Table S1). Notably, p53 (TP53) can bind seven of
the twelve RAG TFs (STAT3, KLF6, MYC, ATF3, CREB, HIF1A, SMAD1),
and STAT3 binds five (KLF4, ATF3, SMAD1, p53, HIF1A). In summary,
although data in neurons remain sparse, evidence from non-neural cell
types strongly supports the possibility that TFs implicated in
regeneration may influence one another’s activity in part through
direct physical association.
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Fig. 2. Existing data establishes functional interactions between regenerationassociated transcription factors. (A) Identified interactions between RAG-TFs are
categorized by mechanism, indicated by color, and by numbers to indicate the source
reference, below. References are provided as hyperlinks in Supplementary Table S1.
(B–E) Existing databases were used to identify interactions between RAG-TFs.
STRINGdB identified physical binding between TFs (B), TRRUST identified
transcriptional hierarchies (C), TRANSPATH and IPA identified cross-regulation through
signaling intermediates (D), and combined IPA, literature mining, and ENCODE data
identified factors that co-occupy regulatory DNA regions (E).

2.1. Implications for discovery
Physical binding between TFs is perhaps the most
straightforward type of interaction to identify. Datasets and network
tools that include physical interactions, although built largely from
non-neural cell types,14,24,31,44,60 are readily available and are already
being used to help prioritize TFs of interest in the context of
regeneration research.13,77,79 A driving assumption of this approach is
that TFs with large numbers of known interactions act as hub proteins
and are thus high priority targets for functional intervention. Although
certainly valid, an important caveat to this assumption is that the
number of known physical interactions for each TF is highly influenced
by the interest that TF has previously received, mostly in non-neural
cell types. For example, a Pubmed search for p53 identifies >80,000
manuscripts, STAT3 identifies >15000, and a search for KLF6 yields
less than 400. Thus it is perhaps unsurprising that the number of
known interactions with other RAG TFs is higher for p53 and STAT3.
When extrapolating available network data to prioritize TFs for
regenerative axon growth, care must to taken to avoid a self-
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reinforcing interest in well-studied factors, at the expense of TFs that
may be less well studied but functionally important.
Unbiased methods are available to discover physical interactions
between TFs. For example, novel TF binding partners can be identified
by proteomic analysis involving immunoprecipitation with mass
spectrometry.28 In a complementary approach, the spatial distribution
of TF binding in the genome can be used to predict possible physical
interactions.82 First, chromatin immunoprecipitation and high
throughput sequencing (ChIP-Seq) can be used to determine genomewide locations of binding by TFs of interest. Then, bioinformatic tools
are used to scan adjacent sequences for recognition motifs of potential
partner TFs, with particular attention paid to promoter and enhancer
regions for genes of interest, in this case, regeneration-associated
genes. If two TFs bind one another and then additionally bind DNA,
this can be detected in TF binding sites in very close proximity.
Software packages are now available for this approach.50 In this way,
starting from a TF that is known to promote regeneration, it would be
possible to identify other TFs that commonly bind, which would act to
prioritize candidate TFs in subsequent co-expression functional tests.

2.2. Implications for functional intervention
The prevalence of TF/TF interactions at the protein level raises
important considerations of stoichiometry. The importance of TF
stoichiometry is well established for efficient cellular reprogramming,58
and it is likely that efforts to improve axon growth by delivery of
multiple TFs will similarly depend on optimal ratios of co-expression.
For example, the observation that JUN-ATF3 heterodimers have been
shown to drive strong transcriptional activation, while ATF3
homodimers act to repress transcription, raises the possibility that the
phenotypic effects of forced co-expression will vary according to the
relative levels. An excess of ATF3 over JUN could facilitate homodimer
formation, tilting the balance toward repression. This issue is
significant because in most standard methods of gene delivery (e.g.
plasmid transfection or viral delivery) the level of protein production is
quite variable and difficult to control. In this way, experimental tests of
forced co-expression could miss possible ratio-specific synergies. It is
even possible that uncontrolled stoichiometry might help explain
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differences in the reported efficacy of JUN/ATF3 co-expression in
promoting sensory axon growth.13,22
One possible solution to achieve more controlled stoichiometry
is polycistronic expression of multiple factors from the same construct.
If approximately equivalent levels of two TFs is desired, a 2A-peptide
approach can be utilized.11,75 In this way, although individual cells will
still receive varying levels of TFs, the ratio of the two will be much
more consistent. Alternatively, a dual promoter design in which each
TF is under the control of a different promoter, could enable skewed
ratios by selecting promoters with differing levels of activity in the cell
type of interest.48 In addition, when the optimal ratio is unknown, it
should also be possible to take advantage of inducible promoters to
systematically vary the production of exogenously expressed TFs. For
example, it was recently found using a Tet-on plasmid and varying
levels of doxycyclin that the growth-promoting effects of HIF1A are
concentration dependent.16 This approach could be extended to dualoverexpression experiments to systematically test a range of
expression ratios. Finally, in situations in which particular TF–TF
binding is desired, so-called “tethered” constructs can be constructed
in which two TFs are produced as a single protein, with the two units
linked by a flexible amino acid tether. This strategy has been used to
force interactions that favor motorneuron development,26 and notably,
has been used to force Jun/ATF3 cooperativity.4 Thus when
contemplating co-expression of pro-regenerative TFs that can
potentially physically interact, similar strategies to control
stoichiometry and association should be considered.
An additional complication is the potential for extra-nuclear
activities by TFs. One prominent example is STAT3, which in addition
to the nucleus, is also known to localize to the cytoplasm and
mitochondria in CNS neurons.49,68,92 In early embryonic spinal
motorneurons, growth-promoting effects of cytoplasmic STAT3 are
largely independent of transcription,68 driven instead by axonal STAT3
stabilizing microtubules. In adult retinal ganglion cells, viral treatment
of mitochondrial STAT3 along with constitutively-active STAT3 was
more effective in promoting optic nerve regeneration than either
treatment alone.49 Therefore, it is important to consider potential nonnuclear localization of RAG TFs when overexpressed, which could
variably impact axon regeneration. One approach to do so involves
Neuroscience Letters, (December 2016). DOI. This article is © Elsevier and permission has been granted for this version to
appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed
or hosted elsewhere without the express permission from Elsevier.

8

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

conventional cloning techniques and the overexpression of DNAbinding mutants or the addition of nuclear localization signals (NLS) or
Nuclear export signals (NES).49 Alternatively, recent advances in
synthetic biology allow for precise and reversible control of nuclear
translocation of proteins in response to light-stimulation, a potentially
powerful approach to distinguish nuclear from extra-nuclear functions
of TF proteins.86

3. Transcriptional cross-regulation
Transcription factors can potentially elevate or suppress the
transcription of “downstream” TFs by directly targeting relevant
promoter or enhancer regions (Fig. 1). In this model, an early wave of
TFs important for axon growth could potentially act to initiate
secondary cascades of additional pro-regenerative TFs. Alternatively,
pro-regenerative TFs might also trigger homeostatic mechanisms in
which they activate expression of TFs that then act to limit
regeneration.
The focus here is on direct transcriptional regulation between
TFs, which requires stringent experimental evidence. A continuum of
experimental approaches provide varying degrees of certainty for
direct transcriptional regulation. Correlative experiments, in which
forced expression or knockdown of one TF leads to a change in
expression of a second, hint at transcriptional cross-regulation but
can’t distinguish direct transcriptional activation from indirect
consequences of downstream effector proteins. For instance, in
sensory neurons responding to peripheral injury, knockdown of SOX11
leads to reduced ATF3 expression, and in oligodendrocyte precursor
cells, activation of STAT3 leads to elevated transcription of KLF6.35,41
These data hint at transcriptional cross-regulation, but a mechanism of
direct transcriptional regulation was not established.
To make a strong case for direct transcriptional regulation, two
additional types of data are needed. First is evidence for binding of a
TF to the regulatory region(s) of the putative target TF. This evidence
can be purely predictive, such as scanning promoter/enhancer
sequences for canonical TF binding motifs, can involve in vitro binding
(e.g. gel shift mobility assays), or can be performed in vivo (chromatin
immunoprecipitation- ChIP). ChIP provides the strongest evidence for
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binding, although it must be kept in mind that binding of TFs to
specific genomic loci is highly cell-type specific.28 Second, after binding
is established, functional evidence for transcriptional regulation by TF
binding (e.g. luciferase assays) is also needed. In general, strong
evidence for the ability of RAG TFs to bind and regulate other TFs is
scarce in neurons, but can be found in other cell types (Fig. 2 and
Supplementary Table S1). Intriguingly, STAT3 transcriptionally
regulates 4 other RAG TFs, KLF6, KLF4, MYC, and HIF1A (Fig. 2C).
Three of these STAT3 targets in turn transcriptionally regulate
additional downstream RAG TFs, hinting at a potential transcriptional
hierarchy among RAG TFs. In addition, p53 binds the ATF3 promoter
and activates transcription, while ATF3 binds and represses the p53
promoter, suggesting a loop of feedback inhibition.38,90 These data hint
that similar transcriptional relationships between RAG TFs may
regulate axon growth.

3.1. Implications for discovery
In principle, transcriptional relationships between RAG TFs
should be relatively straightforward to identify. Initial analyses would
involve transcriptional profiling of neurons after forced expression or
knockdown of one RAG TF, in order to determine whether the
expression of other RAG TFs changes in response. Follow-up motif
analysis of promoter/enhancer regions, ChIP, and expression assays
(e.g. luciferase) could then rule in or out direct transcriptional
relationships. Indeed, this discovery workflow has been applied to
single target genes in regenerating neurons,31,78 and genome-wide in a
variety of non-neural cells (See Fig. 2, Supplementary Table S1,
and41). These transcriptional relationships are described in searchable
databases including IPA and TRRUST31,79 and raise the possibility that
similar relationships may exist in neurons. In summary, genome-wide
discovery efforts focused on neurons and targeted verification of
predicted transcriptional relationships offer a rapid way to expand
knowledge of TF networks in regenerative neuroscience.

3.2. Implications for functional intervention
Greater clarity regarding transcriptional relationships between
RAG TFs would be quite useful in two ways. First, clarifying TF
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cascades and hierarchical relationships in regeneration would assist in
selecting top-level TFs that can drive secondary expression of
additional TFs for maximal effect. In one simple example, if the
observation that STAT3 activation leads to elevated KLF6 expression
(above) holds true in a neuronal context, this information would
prioritize STAT3 interventions for combinatorial gain. As hierarchical
cascades are clarified, perhaps a relatively small set of core TFs could
be identified whose expression might achieve widespread activation of
a larger cohort of needed TFs. Second, knowledge of transcriptional
hierarchies might help avoid unintended and counter-productive
consequences of TF interventions. Indeed, it is clear that proregenerative TFs can engage homeostatic mechanisms that ultimately
dampen their pro-regenerative activities. One well-studied example
involves STAT3, which upregulates the expression of SOCS3, which in
turn represses STAT3 activity. Genetic deletion of SOCS3 is now a
well-established means to enhance STAT3 activity.73 By analogy, it is
conceivable that pro-regenerative TFs engage homeostatic
transcriptional mechanisms that act to repress expression of other
RAG TFs; such a relationship is hinted at by the upregulation of KLF4,
a growth-repressive TF, by STAT3.30 Identifying such homeostatic
circuits, and devising ways to circumvent them, may amplify net proregenerative effects. In summary, increased information regarding
transcriptional relationships between pro-regenerative factors will
facilitate combinatorial strategies that are maximally efficient by
favoring top-level factors, and which may help avoid unintended
(negative feedback) consequences of TF intervention.

4. Cross-activation through downstream effectors
The activity of TFs is controlled not only by abundance, but also
through a variety of post-translational modifications and the
availability of co-factors. Thus, in addition to the direct transcriptional
relationships considered above, TFs can influence one another’s
activity indirectly by altering the expression of upstream regulators of
a second TF (Fig. 1C). For example, KLF factors do not appear to alter
STAT3 expression, but may influence STAT3 activity through upstream
regulators. Specifically, in oligodendrocyte precursor cells, KLF6 binds
and activates the promoter region of gp130, a cytokine receptor,
which in turn elevates JAK signaling and STAT3 activation.41 Similarly,
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in neural stem cells, KLF4 transcriptionally activates cytokine receptors
and JAK3, leading to STAT3 phosphorylation and activation.77 In
adipocytes, HIF1A also affects STAT3 activity through transcriptional
activation of SOCS3, an inhibitor of STAT3 signaling.36 In
mesenchymal stem cells, SOX11 transcriptionally increases expression
of BMP receptors, which leads to activation of SMAD1.68 In hepatic
tumors, KLF6 transcriptionally represses MDM2, a major inhibitor of
p53, and thus acts to increase p53 activity.76 Additional examples can
be found in Fig. 2 and Supplementary Table S1, illustrating widespread
occurrence of TF cross regulation through signaling mechanisms.

4.1. Implications for discovery
For RAG TFs with regulatory PTMs that are well established and
readily detectable (e.g. effective phospho-specific antibodies),
signaling cross-talk from other TFs is relatively easy to detect. For
example, the activity of STAT3, SMAD1, and JUN are all known to be
controlled in part by phosphorylation, and phospho-specific antibodies
exist for all three. Thus, forced expression or knockdown of a battery
of RAG TFs could be followed by assessment of changes in
phosphorylation state. Similarly, when upstream regulators of TFs are
known (e.g. MDM2 as a well-established repressor of p53 activity, or
SOCS3 as a STAT3 inhibitor), the abundance of these regulators can
be readily monitored after manipulation of other TFs. The situation is
much more challenging, however, for TFs such as SOX11 and KLFs.
Although some information regarding KLF phosphorylation and
acetylation is available, there remains a dearth of knowledge regarding
upstream regulators of activity for these zinc finger factors.3,57 Thus for
some factors, detection of TF–TF interactions via signaling cross-talk
awaits more information regarding regulatory modifications and the
development of PTM-specific antibodies.

4.2. Implications for functional intervention
Perhaps the most important implication of signaling-based
cross-talk between TFs is the possibility that such cross-regulation
might could be mimicked or blocked by pharmacological agents. That
is, if functional synergy between two TFs results in part from the
ability of one factor to activate another TF through signaling
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intermediates, (e.g. JAKs or JNKs), then pharmacological activation of
these intermediates may amplify the synergy. In addition, as
discussed above regarding transcriptional relationships, proregenerative TFs may engage homeostatic growth-suppressive
signaling mechanisms. In that scenario, pharmacological inhibition of
these pathways might increase net growth promotion. Finally, whether
the goal is to amplify or dampen downstream signaling cascades that
link TFs, an alternative to pharmacology is forced expression of mutant
TFs that mimic or prevent the relevant modifications (e.g. phosphormimic or −null mutants). As one example, if KLF6 leads to elevated
STAT3, then perhaps this effect might be amplified by expression of
constitutively active STAT3 mutations.49 Thus, increased understanding
of signaling cascades affected by TF expression is important for
regenerative neuroscience by guiding the rational development of TF
modifications and potential combination with pharmacological agents.

5. Co-occupancy of regulatory DNA
Gene transcription is regulated by the binding of TFs to cisregulatory DNA sequences. These elements are often conceptually
divided into short-range elements such as promoter regions, found
within 1kB 5′ to transcriptional start sites, and long-range regulatory
elements such as enhancer regions that can influence transcription
from locations as far as 100 s of Kb in either the 5′ or 3′ direction.
Although data from neurons remains limited, extensive ChIP-based
profiling datasets have emerged for a range of TFs in a variety of cell
types, creating an increasingly clear picture of genome-wide binding.
For example, the ENCODE project has generated genome-wide ChIPSeq data for more than 100 TFs, complemented by genome-wide
profiling of chromatin accessibility and epigenetic modifications. These
integrated datasets allow powerful correlative analysis between TF
binding location, chromatin status and accessibility, and expression at
loci across the genome.83 A key insight to emerge from these datasets
is that transcription is rarely predicted by the binding of any single
factor, but rather reflects binding by multiple TFs to both promoter and
enhancer elements. For example, in developing erythrocytes, cooccupancy by three TFs, TAL1, GATA1, and SMAD1, proved to be a
predictor of enhancer activity with a remarkable 80% accuracy; single
binding by any one factor was much less predictive.20 Similarly,
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genome-wide binding by more than 100 TFs, generated by the
ENCODE project, was analyzed for co-occupancy by TFs. Interestingly,
when considering genes whose expression is highly cell-type specific,
the cells in which transcription selectively occurred were marked by
binding of between 8 and 12 distinct factors to the promoter region,
whereas non-expressing cell types showed binding by zero to three
factors. Again, occupancy by multiple TFs, and no single TF, predicts
expression.82
A variety of mechanisms can explain additive or synergistic
transcriptional effects of co-occupancy. One possibility is that two
factors interact with different, widely separated regulatory regions. For
example, one TF may bind a proximal promoter but confer minimal
transcriptional activation until a second TF binds and activates a distal
enhancer. Other mechanisms depend on co-occupancy of different TFs
in close proximity on the same promoter or enhancer. Recruitment of
multiple TFs may facilitate activation by leading to non-linear gains in
nucleosome displacement,54,81 by enhancing the association of coactivators such as p300 (transcriptional synergy),53 initiation of local
DNA bending by TFs (eg HMG1) which may increase the affinity for
other TFs.23,55 In all cases, the critical point is that co-occupancy
models indicate that TFs can profoundly influence one another’s
transcriptional output without necessarily engaging in direct binding or
reciprocal regulation of abundance/activity (Fig. 1D).

5.1. Implications for discovery
Most fundamentally, the potential for functional interaction
through co-occupancy means that in the search for functional
combinations of TFs to promote axon growth, sole reliance on protein–
protein and transcriptional relationships may fail to detect important
network members. Analysis of the spatial relation of TF binding sites
provides an alternative means to uncover possible co-regulators. This
strategy involves 1) genome-wide analysis of binding by TFs of
interest in a relevant cell type and 2) scanning of nearby or
functionally grouped sequences (e.g. disparate enhancers that
regulate a common gene) for statistically over-represented binding
motifs of other TFs. An illustrative example comes from the study of
motorneuron development. Starting from previous observations that
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an LHX1-ISL1 tethered construct promotes MN differentiation, Lee et
al. performed ChIP-Seq analysis to identify several thousand binding
sites in differentiating stem cells.43 Motif analysis revealed that 80% of
these sites were in close proximity to predicted binding sites for
STAT3, suggesting a previously unknown cooperative role. Indeed,
follow-up experiments revealed an important functional requirement
for STAT3 in recruitment of the LHX1-ISL1 construct and MN
differentiation. The basic strategy of using genome-wide occupancy
data to discover new members of TF regulatory networks has been
employed with great effect in the study stem cell differentiation,59
cancer biology,89 hematopoetic differentiation29 and more. In addition,
an integrated analysis of TF ChIP-seq data from multiple cell types
mapped a co-occupancy matrix for more than 100 TFs, including 7
RAG TFs. These analyses reveal intriguing examples of co-occupancy
by RAG TFs, including nearly 50% co-occupancy by STAT3 with both
MYC and JUN (Fig. 2).
What is needed to employ a similar strategy in regenerative
neuroscience? First, and most fundamentally, the requisite ChIP-Seq
datasets must be created. In comparison to other fields (above)
regenerative neuroscience has made little progress in developing
datasets of genome-wide binding by RAG TFs in relevant cell types
(e.g. regenerating peripheral neurons or early developmental CNS
neurons). TF binding patterns can change dramatically between cell
types and even within a single cell type across development,7,25,28
Nevertheless, ChIP-seq datasets are available for RAG TFs in the
context of neural differentiation (SOX117) and in adult activitydependent plasticity (AP1 factor FOS,51). Data are also available from
non-neural cell types for KLF6,41 STAT3,33 SMAD1, MYC, KLF4,15 JUN,46
and ATF3.91 Thus, until neuron-specific datasets are developed, these
data may serve as first-pass indicators of potential co-occupancy
relationships for RAG TFs.
Second, because the majority of TF binding sites occur at great
distances from transcription start sites, an ongoing challenge in all
fields is to identify which of these sites correspond to genuine cisregulatory (e.g. enhancer) regions. To date, no features of the primary
DNA sequence have been identified that can reliably distinguish
enhancers from non-regulatory regions. Instead, biochemical
signatures specific to enhancers have been used. For instance,
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enhancer regions tend to be nucleosome depleted, so one approach
involves profiling chromatin accessibility genome-wide using DNAaseseq,21 or the more recent ATAC-Seq.19 For a more targeted approach,
presence of histone marks such as H3K4me132 or H3K27Ac,18 and
binding by regulatory factors like p300,12,52,80 or even binding by
specific TFs20 have been used to predict enhancer function across the
genome, with varying success. Although a great majority of genomewide efforts to identify enhancer regions have been performed in nonneuronal cell types, genome-wide sequencing for a battery of promoter
and enhancer specific histone marks have been carried out on brain
tissue derived from embryonic mice as part of the ENCODE project1
(https://www.encodeproject.org) and on adult brain tissue as part of
the Roadmap epigenomics project8
(http://www.roadmapepigenomics.org). A major caveat to using these
datasets is that the heterogeneous source material likely dilutes the
signatures of specific cell types. In silico platforms exist to tackle this
issue, in which binding profiles/expression profiles are tested against
profiles from cell-type specific genes, to correlate which cell-type best
represents the mixed-cell dataset.25,40
Finally, once enhancer regions are identified, their tremendous
distance from gene loci creates ambiguity regarding the gene(s) under
regulation. Although the assumption is often made that the relevant
enhancers are those located nearest to a gene of interest, this
assumption is debatable.88 In summary, although progress in other
fields illustrates the tremendous potential of co-occupancy analysis to
reveal TF–TF interactions of importance to regenerative neuroscience,
development of this approach must await basic information regarding
the distribution of TF binding, enhancers active in neurons, and
perhaps clearer mapping of enhancers to gene loci.

5.2. Implications for therapy
Strategies to select optimal combinations of TFs will be strongly
influenced by the specific mechanisms through which co-occupying TFs
influence transcription. At one extreme, TFs could be considered to
make additive contributions to similar processes, either positively or
negatively.63 For instance, each individual factor could be partially
effective at displacing nucleosomes, adding or removing epigenetic
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marks that favor activity, or recruiting a common set of activators or
repressors. In this model, TFs are effectively functionally
interchangeable, and the strategy for optimal manipulation is relatively
straightforward. Once regulatory elements and their bound TFs are
identified, this model would favor simultaneous expression of the
maximal number of transcriptional activators and/or maximal
knockdown of transcriptional repressors.
A very different picture emerges when considering the likelihood
that co-occupying TFs achieve functional synergy by regulating diverse
and complementary aspects of transcriptional activation. That is, some
TFs may primarily modify epigenetic marks, others may enhance
accessibility through chromatin bending, and others may recruit
specific co-factors. An important implication of this model is that
priming of chromatin by one TF could be a pre-requisite for
recruitment of others. Indeed, an emerging concept in stem cell
biology is that some TFs act as so-called “pioneer factors” and play an
essential role in accessing closed chromatin and remodeling it to allow
subsequent binding by additional TFs.34,71,72 An interesting example
comes from genome-wide profiling of chromatin accessibility and cooccupancy of AP1 and Glucocorticoid receptor (GR). This study
revealed that AP1 binding preceded GR binding, creating an accessible
chromatin state around critical genomic loci, and was essential for
subsequent GR binding and activity.9
The first implication of this model is that when selecting TF
combinations for maximal effect, what matters most is not the number
of TFs but rather the diversity of mechanisms that can be engaged.
The issue of chromatin accessibility is particularly important, as single
or even sets of TFs that normally target important regulatory regions
may be unable to do so without appropriate chromatin remodeling
factors. Overall, careful consideration of TFs that confer
complementary activities, and particular attention to including TFs that
assist in targeted opening of chromatin, may be an effective strategy
to select functional sets of TFs for axon growth.
A second implication is that issues of timing and sequence must
also be considered. It is clear that in some cases, complementary
transcriptional mechanisms must be engaged in a strict order. For
example, pioneer factors must precede other TFs in order to prepare
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the chromatin landscape for subsequent binding, and significant delays
can exist between the onset of pioneer expression and appropriate
chromatin remodeling. Thus synergistic effects may not be evident
from TF/pioneer co-expression in short-term assays. An additional
challenge is that in some cases early-acting TFs must be silenced
before later-acting factors can be effective. For example, Sox family
members, including the RAG TF SOX11, must be up- and downregulated in strict sequence during early neural differentiation.7 First,
SOX3 binds widely to the genome of neural progenitor cells and acts to
alter epigenetic marks. As the progenitor cells differentiate into
neurons, SOX3 is downregulated and SOX11, which drives early
expression of neural-specific genes important for axon growth, is
upregulated. Interestingly, although SOX3 promotes epigenetic
remodeling that facilitates subsequent SOX11 activity, it also
physically competes with SOX11 to occlude binding; downregulation of
SOX3 is essential for subsequent SOX11 activity. In other words, SOX3
and SOX11 cooperate to activate genes involved in axon growth, but
in a manner that requires SOX3 expression to precede SOX11, and
critically, to be transient. Thus prolonged co-expression of both
factors, which is typical of many common gene delivery techniques,
would not be optimal in this case.
Recent advances offer unprecedented opportunities to answer
questions regarding the role of timing and sequence in transcriptional
output. For example, the GAVPO system, based on light-triggered
dimerization of DNA-binding domains, allows tight control of both the
timing and amount of transgene expression.84 In one relevant
application, GAVPO was used to control Brn2 expression in embryonic
stem cells, in order to query how timing and dose affect the regulatory
network of pluripotency TFs.70 Alternatively, multiple groups have
engineered DNA binding motifs and functional domains such that their
association can be controlled optically.39,61,64 When delivered to cells
these constructs enable tight temporal control of transcriptional
activity, transcriptional repression, or targeted epigenetic
modifications.39,45,61 Thus in principle, multiple TFs can be delivered to
neurons, with the expression or function of one or more factors
regulated by optical stimulation. In this way, by systematically varying
optical stimulation while quantifying rates of axon growth, it should be
possible to determine how the timing and duration of expression of
specific members of multi-TF sets impacts cooperative function.
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6. Conclusions and future prospects
It is likely that multiple, interactive transcriptional programs
must be engaged to restore full regenerative potential in CNS neurons.
How to identify the optimal set of factors, and how to optimally deliver
these factors once identified, are core questions. Progress in other
fields provides a conceptual framework to classify TF interactions, and
provides a roadmap for progress in regenerative neuroscience.
Techniques are available to establish physical, transcriptional,
signaling, and co-occupancy relationships between TFs. Applying these
to neural cell types, with particular attention paid to comparing
regeneration-competent and −incompetent states, will establish
transcription factor regulatory networks that underlie axon growth. In
turn, these networks can be targeted using strategies driven by the
specifics of the identified interactions (tethered constructs, mutant
forms, complementary epigenetic functions, etc.). Although applying
this framework to neurons entails considerable effort, it promises rapid
progress in clarifying and leveraging TF interactions for functional gain
after CNS injury.
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